Stocks finish week halfway back following global sell-off

After the XBI fell nearly 6% from July 31 to Aug. 5, the biotech index clawed back nearly half of that to finish the week down 3.6% since the start of the month.

The NASDAQ Biotechnology Index (NBI) and broader markets followed suit, with the NASDAQ 100 index the worst performer of the group...